- Home
- CPHI vs NCNA Comparison
CPHI vs NCNA Comparison
Compare CPHI & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHI
- NCNA
- Stock Information
- Founded
- CPHI N/A
- NCNA 1997
- Country
- CPHI China
- NCNA United Kingdom
- Employees
- CPHI N/A
- NCNA N/A
- Industry
- CPHI Biotechnology: Pharmaceutical Preparations
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- CPHI Health Care
- NCNA Health Care
- Exchange
- CPHI Nasdaq
- NCNA Nasdaq
- Market Cap
- CPHI 4.2M
- NCNA 4.4M
- IPO Year
- CPHI N/A
- NCNA 2017
- Fundamental
- Price
- CPHI $0.19
- NCNA $1.23
- Analyst Decision
- CPHI
- NCNA Buy
- Analyst Count
- CPHI 0
- NCNA 2
- Target Price
- CPHI N/A
- NCNA $25.00
- AVG Volume (30 Days)
- CPHI 380.9K
- NCNA 130.9K
- Earning Date
- CPHI 11-13-2024
- NCNA 12-03-2024
- Dividend Yield
- CPHI N/A
- NCNA N/A
- EPS Growth
- CPHI N/A
- NCNA N/A
- EPS
- CPHI N/A
- NCNA N/A
- Revenue
- CPHI $5,544,620.00
- NCNA N/A
- Revenue This Year
- CPHI N/A
- NCNA N/A
- Revenue Next Year
- CPHI N/A
- NCNA N/A
- P/E Ratio
- CPHI N/A
- NCNA N/A
- Revenue Growth
- CPHI N/A
- NCNA N/A
- 52 Week Low
- CPHI $0.17
- NCNA $1.23
- 52 Week High
- CPHI $1.15
- NCNA $19.40
- Technical
- Relative Strength Index (RSI)
- CPHI 36.69
- NCNA 26.61
- Support Level
- CPHI $0.18
- NCNA $1.26
- Resistance Level
- CPHI $0.21
- NCNA $1.66
- Average True Range (ATR)
- CPHI 0.02
- NCNA 0.09
- MACD
- CPHI -0.00
- NCNA 0.01
- Stochastic Oscillator
- CPHI 16.25
- NCNA 1.15
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.